2026 NPPES data Anatomic Pathology Physician NPI 1962577387 M.D.
Verify on CMS →

AZRA ZARRINPAR, M.D.

Anatomic Pathology Physician in LOS ANGELES, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
218
Medicare Part D claims · 21 beneficiaries · Anatomic Pathology Physician avg: 214
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$107.53
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AZRA ZARRINPAR, M.D. filed 218 Medicare Part D claims in 2023 as a Anatomic Pathology Physician in LOS ANGELES, California, prescribing 89% generic.

218
Part D claims, 2023
89%
generic prescribing
$107.53
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AZRA ZARRINPAR, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

218 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

AZRA ZARRINPAR, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AZRA ZARRINPAR, M.D.?

Quality data not reported

NPI registry status

Active

Issued 11/21/2006

NPI 1962577387

Primary specialty

Anatomic Pathology Physician

Niche

2,597 US NPIs in this specialty

Medicare Part D claims

218 2% vs specialty avg

2023 prescription claims

Specialty avg: 214

Specialty distribution in California

How Anatomic Pathology Physician compares to other specialties among California providers

California providers

Anatomic Pathology Physician share within California

1. Anatomic Pathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Anatomic Pathology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Anatomic Pathology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Anatomic Pathology Physician ABMS/AOA estimate

Est. board-certified rate (Anatomic Pathology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Anatomic Pathology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AZRA ZARRINPAR, M.D. appears in the CMS NPPES registry as a Anatomic Pathology Physician provider holding M.D. credentials at 1700 WESTWOOD BLV, LOS ANGELES, CA, 90024, with a listed phone of (310) 435-1892. NPI 1962577387 was issued on 11/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ZARRINPAR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 218 prescription claims written by this provider, covering 21 Medicare beneficiaries and totaling roughly $11K in drug spend, split 11% brand-name and 89% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Anatomic Pathology Physician is a narrow specialty nationwide, with 2,597 enrolled providers across 54 states and an average of 214 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1700 WESTWOOD BLV
LOS ANGELES, CA 90024

Provider Details

NPI 1962577387
Specialty Anatomic Pathology Physician
Credentials M.D.
Gender Female
NPI Issued 11/21/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AZRA ZARRINPAR, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$108

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to AZRA ZARRINPAR, M.D.. To verify AZRA ZARRINPAR, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

AZRA ZARRINPAR, M.D. — brand share 11.0%
Specialty average (est.)

11% brand-name claims vs 89% generic, on 218 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

218
Total Claims
$11K
Total Drug Cost
21
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
344
Total Day Supply
9,652
Brand vs Generic
11% brand / 89% generic
Brand Drug Cost
$6K
Generic Drug Cost
$5K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
0.60

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AZRA ZARRINPAR, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
27
Metformin Hcl
23
Hydrochlorothiazide
19
Amlodipine Besylate
11
Lisinopril
11
Naproxen
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Anatomic Pathology Physician Overview

How AZRA ZARRINPAR, M.D. fits within the Anatomic Pathology Physician landscape nationally.

2,597
Anatomic Pathology Physician Providers in US
54
States with Anatomic Pathology Physician
214
Avg Claims per Provider

AZRA ZARRINPAR, M.D.'s 218 claims are above the specialty average of 214.

Nearby Anatomic Pathology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ZARRINPAR.

Compare Anatomic Pathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AZRA ZARRINPAR, M.D.'s specialty?
AZRA ZARRINPAR, M.D. specializes in Anatomic Pathology Physician and practices in LOS ANGELES, California. Credentials: M.D..
How much does AZRA ZARRINPAR, M.D. prescribe under Medicare Part D?
In 2023, AZRA ZARRINPAR, M.D. wrote 218 Medicare Part D claims totaling $11K in drug costs for 21 beneficiaries.
Where is AZRA ZARRINPAR, M.D. located?
AZRA ZARRINPAR, M.D. is located at 1700 WESTWOOD BLV, LOS ANGELES, CA, 90024. Phone: (310) 435-1892.
What is AZRA ZARRINPAR, M.D.'s NPI number?
AZRA ZARRINPAR, M.D.'s National Provider Identifier (NPI) is 1962577387, issued on 11/21/2006.
Does AZRA ZARRINPAR, M.D. prescribe more brand-name or generic drugs?
AZRA ZARRINPAR, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $6K in brand drug costs.
How many Anatomic Pathology Physician providers are there in the US?
There are 2,597 Anatomic Pathology Physician providers across 54 states in the US. The average Anatomic Pathology Physician provider writes 214 Medicare Part D claims per year.
What drugs does AZRA ZARRINPAR, M.D. prescribe most often?
Based on 2023 Medicare Part D data, AZRA ZARRINPAR, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Metformin Hcl, Hydrochlorothiazide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AZRA ZARRINPAR, M.D. accept Medicare?
AZRA ZARRINPAR, M.D. appears in CMS Medicare data with 218 Part D claims and 21 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AZRA ZARRINPAR, M.D.'s credentials?
AZRA ZARRINPAR, M.D.'s NPI is 1962577387 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology